EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients

Yuan Dang iD, Jingyun Huang iD, Xing Peng, Yingchao Wang, Jianmin Wang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01188-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Yuan Dang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B virus, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Department of Science and Technology, Fujian University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a prevalent liver cancer associated with global health. The tumor microenvironment’s (TME) microbial composition significantly influences HCC’s development and prognosis. This study analyzed bacterial 16S rRNA genes from liver cancer patients’ tumor, adjacent tumor, and normal tissues, revealing distinct microbiome profiles between tumor and normal tissues. HCC microbiota was more abundant, with Bacteroides , Ochrobactrum , Akkermansia , and Lactobacillus as the most prevalent genera. Hepatitis B virus (HBV)-positive (HBV+) and HBV-negative (HBV−) HCC tissues showed different microbial network patterns, with Bacteroides enrichment in HBV+ tissues being associated with HCC prognosis. HBV is associated with clinicopathological features and serves as an independent prognostic factor in HCC. The study underscores the microbiota’s complexity in HCC and the potential of HBV as a prognostic biomarker post-surgery. This study provides critical insights into the relationship between the microbiota within the TME and HCC, a leading cause of cancer-related mortality. By identifying distinct microbiome profiles in HCC patients, particularly the enrichment of Bacteroides in HBV-positive tissues, our research not only uncovers the complexity of microbial interactions in liver cancer but also highlights the potential of using HBV status as a prognostic biomarker. This could significantly inform personalized treatment strategies and improve clinical outcomes for HCC patients, emphasizing the relevance of microbiome-based diagnostics and therapies in oncology. IMPORTANCE In our study of the tumor microenvironment (TME) in hepatocellular carcinoma (HCC), we used DNA sequencing of bacterial 16S rRNA genes to analyze microbial compositions in tumor, adjacent tumor, and normal tissues from 213 liver cancer patients. Fluorescence in situ hybridization confirmed the presence of microbiota within tumors. Our results showed significant differences in microbiome profiles between tumor and normal tissues, with increased abundance of Bacteroides , Ochrobactrum , Akkermansia , and Lactobacillus in the HCC TME. Hepatitis B virus (HBV) status further stratified these differences, with Bacteroides significantly enriched in HBV-positive tissues and correlating with patient prognosis. Additionally, Bacteroides and Akkermansia showed interdependent population changes. Clinicopathological features, such as tumor size, were associated with HBV status, identifying HBV infection as an independent prognostic factor. These findings highlight the HCC microbiota’s complexity and suggest HBV status as a potential prognostic biomarker, opening avenues for personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B virusBacteriaHepatitis BHumansPrognosisRNA, Ribosomal, 16SMaleTumor MicroenvironmentFemaleMiddle AgedMicrobiotaAgedAdult

Stichwörter der Autor:innen

hepatitis Bhepatocellular carcinomaprognosistumor tissue microbiomeviral load

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • College of Computer and Data Science, Fuzhou University, Fuzhou, China.
  • The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.

ORCID-Profile: Yuan Dang, Jingyun Huang, Jianmin Wang

Förderung

  • Fujian Provincial Department of Science and Technology
  • Fujian University of Traditional Chinese Medicine

Zitieren

APA

Dang, Y., Huang, J., Peng, X., Wang, Y., & Wang, J. (2025). Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01188-25

Vancouver

Dang Y, Huang J, Peng X, Wang Y, Wang J. Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01188-25

BibTeX
@article{Dang2025,
  author = {Dang, Yuan and Huang, Jingyun and Peng, Xing and Wang, Yingchao and Wang, Jianmin},
  title = {Identification of intratumoral bacteria correlated with hepatitis B virus (HBV) levels: a prognostic indicator for patient outcomes in hepatocellular carcinoma patients},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01188-25}
}
Kostenlos starten →